TEMITOPE AJANI: Open Payments
NPI 1215644752 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 29 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $525 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $153 |
| AstraZeneca Pharmaceuticals LP | 7 | $127 |
| Amgen Inc. | 5 | $87 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| Noven Therapeutics, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: AIRSUPRA, Wegovy, OTEZLA, MOUNJARO, Cologuard Collection Kit, BREZTRI, Xelstrym, Veozah.
Industry payments across FL — which companies pay providers there.
